Lv5
968 积分 2024-03-05 加入
Annual review of EGFR inhibitors in 2024
5天前
已完结
Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry
5天前
已完结
An overview of site-specific methods for achieving antibody drug conjugates with homogenous drug to antibody ratio
5天前
已完结
Cancer Throughlines: 25 Years after First Approval, ADCs Continue to Pick up Steam
6天前
已关闭
Hallmarks of Cancer: The Next Generation
13天前
已完结
Non-small-cell lung cancer
15天前
已完结
Current strategies for the discovery and bioconjugation of smaller, targetable drug conjugates tailored for solid tumor therapy
1个月前
已完结
Targeted precision Strike in Extensive-Stage small cell lung Cancer: Current advances and future Perspectives for Antibody–Drug conjugates
1个月前
已关闭
Novel anti-HER2 nanobody-drug conjugates with enhanced penetration of solid tumor and BBB, reduced systemic exposure and superior antitumor efficacy
1个月前
已完结
Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug Conjugates
1个月前
已完结
皖公网安备34019202002308
